Therapeutic compounds for treating dyslipidemic conditions
US7125865B2 · kind B2 · utility
19Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2003 |
| Grant date | Oct 24, 2006 |
| Priority date | — |
| Expiry date | Jul 21, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.